{"id":717,"date":"2020-02-06T15:32:27","date_gmt":"2020-02-06T14:32:27","guid":{"rendered":"http:\/\/invivo.partners\/portoflio_invivo\/gly-cardial\/"},"modified":"2024-03-04T22:03:37","modified_gmt":"2024-03-04T21:03:37","slug":"gly-cardial","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/","title":{"rendered":"GlyCardial"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">Glycardial Diagnostics \u00e9s una empresa que desenvolupa testos de diagn\u00f2stic GlyCardial Diagnostics \u00e9s una empresa <em>spin-off<\/em> de l&#8217;<strong>IR-Hospital de la Santa Creu i Sant Pau<\/strong> i del Consejo Superior de Investigaciones Cient\u00edficas (<strong>CSIC<\/strong>). L&#8217;empresa es centra en el desenvolupament d&#8217;un nou test de diagn\u00f2stic <em>in vitro <\/em>de la <strong>isqu\u00e8mia mioc\u00e0rdica.<\/strong> La tecnologia es basa en la detecci\u00f3 <strong>d&#8217;Apo J-Glyc <\/strong>en sang com a biomarcador per al diagn\u00f2stic preco\u00e7 de la isqu\u00e8mia card\u00edaca i la predicci\u00f3 de l&#8217;evoluci\u00f3 del pacient despr\u00e9s d&#8217;un esdeveniment isqu\u00e8mic. &#8211; <strong>Inactiva<\/strong><\/p>\r\n\r\n\r\n\r\n\r\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[506],"class_list":["post-717","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-healthequity"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GlyCardial - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GlyCardial - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Glycardial Diagnostics \u00e9s una empresa que desenvolupa testos de diagn\u00f2stic GlyCardial Diagnostics \u00e9s una empresa spin-off de l&#8217;IR-Hospital de la Santa Creu i Sant Pau i del Consejo Superior de Investigaciones Cient\u00edficas (CSIC). L&#8217;empresa es centra en el desenvolupament d&#8217;un nou test de diagn\u00f2stic in vitro de la isqu\u00e8mia mioc\u00e0rdica. La tecnologia es basa en\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-04T21:03:37+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/\",\"url\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/\",\"name\":\"GlyCardial - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-02-06T14:32:27+00:00\",\"dateModified\":\"2024-03-04T21:03:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GlyCardial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GlyCardial - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/","og_locale":"ca_ES","og_type":"article","og_title":"GlyCardial - Invivo Partners","og_description":"Glycardial Diagnostics \u00e9s una empresa que desenvolupa testos de diagn\u00f2stic GlyCardial Diagnostics \u00e9s una empresa spin-off de l&#8217;IR-Hospital de la Santa Creu i Sant Pau i del Consejo Superior de Investigaciones Cient\u00edficas (CSIC). L&#8217;empresa es centra en el desenvolupament d&#8217;un nou test de diagn\u00f2stic in vitro de la isqu\u00e8mia mioc\u00e0rdica. La tecnologia es basa en","og_url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/","og_site_name":"Invivo Partners","article_modified_time":"2024-03-04T21:03:37+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/","url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/","name":"GlyCardial - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-02-06T14:32:27+00:00","dateModified":"2024-03-04T21:03:37+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/gly-cardial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"GlyCardial"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo\/717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=717"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tipo_portfolio?post=717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}